A Phase I/II Study of Pixantrone in Patients with an Aggressive Relapsing Remitting (RR) or Secondary Progressive (SP) Multiple Sclerosis (PIXAMS).
Phase of Trial: Phase I/II
Latest Information Update: 22 Oct 2014
At a glance
- Drugs Pixantrone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms PIXAMS
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 04 Jul 2012 Additional trial location (France) added as reported by European Clinical Trials Database record.
- 11 Mar 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History